Stada Expands Oilatum Range To Meet Saudi Arabia’s Skin-Care Needs

Stada launches nine new Oilatum products in Saudi Arabia including “rich moisturising creams for intense hydration, gentle body washes for daily cleansing, and baby-specific products like soothing bath bubbles and head-to-toe wash.”

Stada's Oilatum range (Stada/Stada)

Eczema and dry skin sufferers in Saudia Arabia will be able to draw upon a wider range of Oilatum skin-care solutions thanks to significant investment by German brand owners Stada Arzneimittel.

“At Oilatum, we understand the cycle of dry skin and the challenges it presents for patients with eczema and chronic dryness, particularly in extreme conditions,” commented Ahmed El Barbary, general manager, Stada KSA+.

Atopic dermatitis (eczema) is a chronic condition affecting around 25% of children in Saudi Arabia and around 13% of adults, according to a Saudi Ministry of Health report.

“Recent research highlights an even broader prevalence when considering undiagnosed cases, emphasizing the urgent need for effective treatment options,” Stada added.

Saudi Arabia’s extreme climate, marked by high temperatures, low humidity, and heavy reliance on air conditioning further exacerbates these conditions, the firm continued, “making hydration and skin barrier protection essential components of eczema management.”

The nine new products – taking the range up to 11 in total – include “rich moisturizing creams for intense hydration, gentle body washes for daily cleansing, and baby-specific products like soothing bath bubbles and head-to-toe wash,” Stada explained.

The expanded range was unveiled at an exclusive event in Riyadh in January, which brought together dermatologists, doctors, and pharmacists from across Saudi Arabia and featured medical presentations by global and local experts on the impact of extreme weather conditions on skin health, as well as discussions on advancements in atopic dermatitis treatment.

“By equipping healthcare professionals in Saudi Arabia with these targeted solutions, we aim to help patients effectively manage atopic skin concerns, find relief from persistent irritation, and protect their skin from future discomfort,” El Barbary said.

Stada acquired Oilatum alongside five skin-care brands and a pediatric cough remedy from Haleon – then GlaxoSmithKline Consumer Healthcare – in 2019 for an undisclosed sum.

Stada CEO Peter Goldschmidt told HBW Insight at the time that the six brands had “great potential” for growth, particularly given the German company’s “rich heritage in skin care.”

“The skin-care category is a key focus [for us],” Goldschmidt declared, “and presents significant growth opportunities across territories.”

More from New Products

First At-Home Test For Multiple STIs Gets FDA Clearance

 
• By 

The Visby Medical Women’s Sexual Health Test is the first over-the-counter test cleared by the US Food and Drug Administration to detect chlamydia, gonorrhea and trichomoniasis. It delivers results in about 30 minutes.

Haleon Launches ‘Prescription Strength’ Hayfever Remedy In The UK

 
• By 

Pirilieve Hayfever Relief Tablets contain 120mg fexofenadine hydrochloride, which the firm notes is an active ingredient that was “previously only available behind pharmacy counters.”

Haleon’s US Eroxon Launch Falls Short Of Expectations

 
• By 

Consumer uptake of Eroxon - the first FDA-approved OTC ED treatment available in the US - has been slower than expected, according to Haleon, which says its working with retailers to build awareness.

Haleon Ready To Partner To Deliver Breakthrough CHC Innovation

 
• By 

Start-ups and individuals working on innovative consumer health concepts, in categories such as pain relief and dietary supplements, have the opportunity to access Haleon's resources and expertise to make their ideas a reality.

More from Geography

EU Parliament Agrees To Postpone Due Diligence And Sustainability Reporting Rules

 
• By 

Speaking at a recent AESGP webinar, sustainability expert Onur Durmus called the the European Commission’s “Omnibus” proposals - designed to simplify ESG reporting rules and recently supported by EU Parliament - a “positive development” for the European consumer health industry.

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By 

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

Over The Counter: Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls

 
• By 

HBW Insight catches up with PAGB CEO Michelle Riddalls to chat about the association's new five year plan. Riddalls also reflects on the successes of the last five years, including relaunching the UK Reclassification Alliance, which has published a list of Rx-to-OTC switches the government would like to see applications for. Part one of two.